Who owns Pds Biotechnology Ord?
- Ticker: PDSB
- CUSIP Number: 70465t107
Tip: Access positions for across all investors
Analyze quarterly positions in Pds Biotechnology Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pds Biotechnology Ord stock
Who bought or sold Pds Biotechnology Ord this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.0M | $1.5M | 3% | Dec 2025 |
|
| Vanguard Capital Management | 1.6M | $987k | 100% | Mar 2026 |
|
| Geode Capital Management | 660k | $400k | 27% | Mar 2026 |
|
| BlackRock | 554k | $335k | 6% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 307k | $186k | 100% | Mar 2026 |
|
| William Blair $ Company | 300k | $182k | 20% | Mar 2026 |
|
| Integrys Wealth Advisors | 182k | $110k | 1% | Mar 2026 |
|
| Renaissance Technologies | 177k | $136k | -36% | Dec 2025 |
|
| Armistice Capital | 174k | $105k | 100% | Mar 2026 |
|
| Northern Trust | 144k | $111k | 27% | Dec 2025 |
|
| State Street Corporation | 133k | $103k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 111k | $67k | 1974% | Mar 2026 |
|
| Commonwealth Equity Services | 91k | $55k | -54% | Mar 2026 |
|
| Amussen Hunsaker & Associates | 75k | $58k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 69k | $42k | 0% | Mar 2026 |
|
| Nine Masts Capital | 68k | $41k | 100% | Mar 2026 |
|
| Tempus Wealth Planning | 62k | $37k | 0% | Mar 2026 |
|
| UBS Group | 56k | $34k | -78% | Mar 2026 |
|
| Susquehanna International | 39k | $30k | -59% | Dec 2025 |
|
| XTX Topco | 34k | $26k | 74% | Dec 2025 |
|
| Virtu Financial | 32k | $25k | 100% | Dec 2025 |
|
| Two Sigma Securities | 32k | $19k | 100% | Mar 2026 |
|
| ACT Capital Management | 30k | $18k | 0% | Mar 2026 |
|
| Rockefeller Capital Management | 28k | $17k | 8% | Mar 2026 |
|
| Simplex Trading | 19k | $15k | 54% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 15k | $9.0k | 0% | Mar 2026 |
|
| Raymond James Financial | 14k | $11k | 0% | Dec 2025 |
|
| Wealth Group | 13k | $8.0k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 13k | $7.6k | 100% | Mar 2026 |
|
| United Capital Financial Advisers | 12k | $7.3k | 100% | Mar 2026 |
|
| Citadel Advisors | 11k | $6.8k | 100% | Mar 2026 |
|
| Davenport & Co | 10k | $6.1k | 0% | Mar 2026 |
|
| Grandfield & Dodd | 10k | $6.1k | 0% | Mar 2026 |
|
| Morgan Stanley | 3.9k | $2.0k | -20% | Mar 2026 |
|
| Group One Trading | 3.6k | $2.2k | -9% | Mar 2026 |
|
| Creative Financial Designs | 3.0k | $1.8k | 0% | Mar 2026 |
|
| Tower Research Capital | 2.2k | $1.7k | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 2.0k | $1.5k | 0% | Dec 2025 |
|
| Truvestments Capital | 655.00 | $396.013000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 648.00 | $391.975200 | 0% | Mar 2026 |
|
| SBI Securities | 118.00 | $71.000600 | 8% | Mar 2026 |
|
| Royal Bank of Canada | 75.00 | $0 | -96% | Mar 2026 |
|
| Advisor Group Holdings | 17.00 | $12.999900 | 0% | Dec 2025 |
|
| Beacon Investment Advisory Services | 5.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Pds Biotechnology Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Caption Management | Sep 2025 | 219k | $221k |
| Squarepoint Ops | Dec 2025 | 193k | $148k |
| Intl Fcstone | Dec 2025 | 16k | $12k |
| First Manhattan | Dec 2025 | 15k | $12k |
| Ground Swell Capital | Dec 2025 | 15k | $11k |
| FMR | Sep 2025 | 1.0k | $1.0k |
| Jpmorgan Chase & Co | Sep 2025 | 619.00 | $625.004300 |
| Rialto Wealth Management | Sep 2025 | 400.00 | $404.000000 |